Anne M. Durkan

702 total citations
16 papers, 355 citations indexed

About

Anne M. Durkan is a scholar working on Nephrology, Immunology and Oncology. According to data from OpenAlex, Anne M. Durkan has authored 16 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Anne M. Durkan's work include Renal Diseases and Glomerulopathies (7 papers), Chemokine receptors and signaling (4 papers) and Complement system in diseases (3 papers). Anne M. Durkan is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Chemokine receptors and signaling (4 papers) and Complement system in diseases (3 papers). Anne M. Durkan collaborates with scholars based in Australia, Canada and United Kingdom. Anne M. Durkan's co-authors include R. Todd Alexander, Jonathan C. Craig, Elisabeth M Hodson, Narelle S Willis, EM Hodson, Lisa A. Robinson, Guangying Liu, Rui Min, Giuseppe Femia and Joshua Kausman and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Anne M. Durkan

16 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne M. Durkan Australia 11 198 88 76 76 75 16 355
Hiroya Hasegawa Japan 9 147 0.7× 98 1.1× 117 1.5× 44 0.6× 67 0.9× 30 383
Michael van Husen Germany 8 245 1.2× 102 1.2× 51 0.7× 62 0.8× 70 0.9× 10 363
Lucie Bessenay France 8 221 1.1× 38 0.4× 167 2.2× 48 0.6× 34 0.5× 9 426
Alexis Harris United States 12 165 0.8× 37 0.4× 133 1.8× 19 0.3× 96 1.3× 21 385
Yoshitsugu Kaku Japan 11 260 1.3× 51 0.6× 94 1.2× 30 0.4× 52 0.7× 23 344
François Nobili France 12 271 1.4× 136 1.5× 158 2.1× 115 1.5× 77 1.0× 28 588
Tuula Hölttä Finland 13 231 1.2× 49 0.6× 71 0.9× 36 0.5× 123 1.6× 18 338
Santiago Mendizábal Spain 12 346 1.7× 238 2.7× 110 1.4× 71 0.9× 83 1.1× 30 589
Claire Dossier France 15 367 1.9× 88 1.0× 82 1.1× 28 0.4× 80 1.1× 42 571
H.-V. Gärtner Germany 9 198 1.0× 35 0.4× 97 1.3× 26 0.3× 83 1.1× 17 339

Countries citing papers authored by Anne M. Durkan

Since Specialization
Citations

This map shows the geographic impact of Anne M. Durkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Durkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Durkan more than expected).

Fields of papers citing papers by Anne M. Durkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Durkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Durkan. The network helps show where Anne M. Durkan may publish in the future.

Co-authorship network of co-authors of Anne M. Durkan

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Durkan. A scholar is included among the top collaborators of Anne M. Durkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Durkan. Anne M. Durkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kan, Alex, et al.. (2024). Long‐term renal outcomes of children with cancers treated with platinum‐based chemotherapy: A retrospective chart analysis. Pediatric Blood & Cancer. 72(1). e31404–e31404. 1 indexed citations
2.
Durkan, Anne M., et al.. (2019). Parental understanding of relapsing idiopathic nephrotic syndrome—Where are the knowledge gaps?. Acta Paediatrica. 109(7). 1465–1472. 2 indexed citations
3.
Wang, Yuan Min, Vincent Lee, Geoff Yu Zhang, et al.. (2018). DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice. PLoS ONE. 13(4). e0195657–e0195657. 10 indexed citations
4.
Fox, Lucy C., S. Cohney, Joshua Kausman, et al.. (2018). Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Internal Medicine Journal. 48(6). 624–636. 26 indexed citations
5.
Fox, Lucy C., S. Cohney, Joshua Kausman, et al.. (2018). Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Nephrology. 23(6). 507–517. 22 indexed citations
6.
Durkan, Anne M., Siah Kim, Jonathan C. Craig, & Elizabeth Elliott. (2016). The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study. Archives of Disease in Childhood. 101(4). 387–391. 14 indexed citations
7.
Wang, Yuan Min, Wang Ya, Debbie Watson, et al.. (2013). Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease.. PubMed. 6(3). 326–33. 6 indexed citations
8.
Wang, Yuan Min, Vincent Lee, Richard Phoon, et al.. (2012). DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration.. PubMed. 5(1). 24–33. 7 indexed citations
9.
Durkan, Anne M. & R. Todd Alexander. (2011). Acute Kidney Injury Post Neonatal Asphyxia. The Journal of Pediatrics. 158(2). e29–e33. 90 indexed citations
10.
Tole, Soumitra, Anne M. Durkan, Yiwei Huang, et al.. (2010). Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion. American Journal of Physiology-Cell Physiology. 298(6). C1469–C1480. 11 indexed citations
11.
Alexander, R. Todd, Anatoly Malevanets, Anne M. Durkan, et al.. (2007). Membrane Curvature Alters the Activation Kinetics of the Epithelial Na+/H+ Exchanger, NHE3. Journal of Biological Chemistry. 282(10). 7376–7384. 28 indexed citations
12.
Durkan, Anne M., R. Todd Alexander, Guangying Liu, et al.. (2006). Expression and Targeting of CX3CL1 (Fractalkine) in Renal Tubular Epithelial Cells. Journal of the American Society of Nephrology. 18(1). 74–83. 30 indexed citations
13.
Durkan, Anne M., et al.. (2005). Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database of Systematic Reviews. CD002290–CD002290. 21 indexed citations
14.
Ramage, Ian J. & Anne M. Durkan. (2003). Principles of management in chronic renal failure. Current Paediatrics. 13(7). 496–501. 4 indexed citations
15.
Durkan, Anne M., et al.. (2001). Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database of Systematic Reviews. CD002290–CD002290. 16 indexed citations
16.
Durkan, Anne M., Elisabeth M Hodson, Narelle S Willis, & Jonathan C. Craig. (2001). Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials. Kidney International. 59(5). 1919–1927. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026